
Dave Cooney
David Cooney is the Head of GTM strategy at HelixAI and former Strategic Client Partner at Causaly AI and former Associate Partner at McKinsey, focused on AI in life sciences R&D. He has led GTM strategy, value proposition design, and enterprise partnerships across top-20 pharma, building multimillion-dollar pipelines and shaping AI product-packaging and partnership
Helix AI
Website: https://helixai.com/
HelixAI is a specialist scientific technology company focused on accelerating research and development for biopharmaceutical organizations. Its platform, JarvisAI, enables scientific teams to design and execute in silico R&D workflows that support a wide range of operations from early-stage drug discovery to scale-up and bioproduction. By integrating scientific data from public, private and client domains along with computational models and AI-driven orchestration, JarvisAI helps researchers explore hypotheses more efficiently and prioritize the most promising drug candidates for further development. This approach supports better, faster decision-making combined with optimization of scientific and wet-lab resources.





